Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 482

1.

The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy.

Ahmed S, Berzon RA, Revicki DA, Lenderking WR, Moinpour CM, Basch E, Reeve BB, Wu AW; International Society for Quality of Life Research.

Med Care. 2012 Dec;50(12):1060-70. doi: 10.1097/MLR.0b013e318268aaff.

PMID:
22922434
2.

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Basch E, Abernethy AP, Mullins CD, Reeve BB, Smith ML, Coons SJ, Sloan J, Wenzel K, Chauhan C, Eppard W, Frank ES, Lipscomb J, Raymond SA, Spencer M, Tunis S.

J Clin Oncol. 2012 Dec 1;30(34):4249-55. doi: 10.1200/JCO.2012.42.5967. Epub 2012 Oct 15. Review.

PMID:
23071244
4.

Defining comparative effectiveness research: the importance of getting it right.

Sox HC.

Med Care. 2010 Jun;48(6 Suppl):S7-8. doi: 10.1097/MLR.0b013e3181da3709.

PMID:
20473202
5.

Using patient-reported outcomes in clinical practice: challenges and opportunities.

Lohr KN, Zebrack BJ.

Qual Life Res. 2009 Feb;18(1):99-107. doi: 10.1007/s11136-008-9413-7. Epub 2008 Nov 25.

PMID:
19034690
6.

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.

Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z.

Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y. Epub 2013 Jan 4. Review.

PMID:
23288613
7.
8.

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D.

Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.

9.

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.

Willke RJ, Burke LB, Erickson P.

Control Clin Trials. 2004 Dec;25(6):535-52. Review.

PMID:
15588741
10.

Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations.

Snyder CF, Aaronson NK, Choucair AK, Elliott TE, Greenhalgh J, Halyard MY, Hess R, Miller DM, Reeve BB, Santana M.

Qual Life Res. 2012 Oct;21(8):1305-14. doi: 10.1007/s11136-011-0054-x. Epub 2011 Nov 3. Review.

PMID:
22048932
11.

The methods of comparative effectiveness research.

Sox HC, Goodman SN.

Annu Rev Public Health. 2012 Apr;33:425-45. doi: 10.1146/annurev-publhealth-031811-124610. Epub 2012 Jan 3. Review.

PMID:
22224891
12.

Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research.

Snyder CF, Jensen RE, Segal JB, Wu AW.

Med Care. 2013 Aug;51(8 Suppl 3):S73-9. doi: 10.1097/MLR.0b013e31829b1d84.

13.

Patient-reported outcomes in cancer: a review of recent research and policy initiatives.

Lipscomb J, Gotay CC, Snyder CF.

CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300. Review.

14.

Taking PROs and patient-centered care seriously: incremental and disruptive ideas for incorporating PROs in oncology practice.

Donaldson MS.

Qual Life Res. 2008 Dec;17(10):1323-30. doi: 10.1007/s11136-008-9414-6. Epub 2008 Nov 9.

PMID:
18991021
15.

A translation table for patient-centered comparative effectiveness research: guidance to improve the value of research for clinical and health policy decision-making.

Tunis SR, Messner DA, Mohr P, Gliklich RE, Dubois RW.

J Comp Eff Res. 2012 May;1(3):259-62. doi: 10.2217/cer.12.22.

16.

Perioperative comparative effectiveness research.

Memtsoudis SG, Besculides MC.

Best Pract Res Clin Anaesthesiol. 2011 Dec;25(4):535-47. doi: 10.1016/j.bpa.2011.08.004. Review.

PMID:
22099919
18.

The applications of PROs in clinical practice: what are they, do they work, and why?

Greenhalgh J.

Qual Life Res. 2009 Feb;18(1):115-23. doi: 10.1007/s11136-008-9430-6. Epub 2008 Dec 23.

PMID:
19105048
19.

Can CER be an effective tool for change in the development and assessment of new drugs and technologies?

Brixner DI, Watkins JB.

J Manag Care Pharm. 2012 Jun;18(5 Supp A):S06-11.

PMID:
22663293
20.

Supplemental Content

Support Center